Recent Updates
Recently added Catalysts
BBIO Positive Sentiment Score: 70/100

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Monday, June 2, 2025 1 min read
Key Takeaway: BridgeBio Pharma, Inc. has announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference 2025, set to occur on June 9 in Miami, FL. Members of the management team will engage in a fireside chat during the event, allowing them to discuss the company's focus on genetic diseases. Interested parties can access a live webcast of the presentation through BridgeBio's investor section, with a replay available for 30 days afterward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prestigious healthcare conference enhances visibility.
  • Opportunity to share insights on genetic diseases with a wider audience.

Full Press Release Details

PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 in Miami, FL on Monday, June 9 at 8:40 am ET.
To access the live webcast of BridgeBio’s presentation during the fireside chat, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.
About BridgeBio Pharma, Inc.
BridgeBio Media Contact:
Bubba Murarka, Executive Vice President
contact@bridgebio.com
BridgeBio Investor Contact:
Chinmay Shukla, VP Strategic Finance

Frequently Asked Questions

When is BridgeBio's fireside chat at the Goldman Sachs Conference?

BridgeBio's fireside chat is scheduled for June 9, 2025, at 8:40 am ET.

How can I watch BridgeBio's live webcast?

Visit the 'Events & Presentations' section on BridgeBio's investor website for access.

Will the webcast be available after the event?

Yes, a replay of the webcast will be available for 30 days post-event.

Who can be contacted for media inquiries at BridgeBio?

Bubba Murarka is the media contact for BridgeBio.

Who is the investor contact at BridgeBio?

Chinmay Shukla serves as the VP of Strategic Finance for investor inquiries.

Tags: BBIO Viatris Investor Conferences Healthcare BridgeBio Goldman Sachs healthcare conference genetic diseases biopharmaceutical
Last updated: Jun 2, 2025